Edition:
United States

People: Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.65USD
21 Feb 2017
Change (% chg)

$0.01 (+1.56%)
Prev Close
$0.64
Open
$0.64
Day's High
$0.65
Day's Low
$0.64
Volume
14,746
Avg. Vol
28,117
52-wk High
$712.00
52-wk Low
$0.02

Faupel, Mark 

Dr. Mark L. Faupel, Ph.D., is Chief Operating Officer, Director of Guided Therapeutics Inc. He is currently serves as a managing member of Shenghuo Medical, LLC (“Shenghuo”), a company with licensing rights in several Asian countries for the Company’s LuViva Advanced Cervical Scan. He previously served on the Company’s board of directors through 2013 and has more than 30 years of experience in developing non-invasive alternatives to surgical biopsies and blood tests, especially in the area of cancer screening and diagnostics. Dr. Faupel was co-founder of the Company and also served as the Company’s Chief Executive Officer from May 2007 through 2013. Prior thereto was the Company’s Chief Technical Officer from April 2001 to May 2007. Dr. Faupel has served as a National Institutes of Health reviewer, is the inventor on 20 U.S. patents and has authored numerous scientific publications and presentations, appearing in such peer-reviewed journals as The Lancet. Dr. Faupel earned his Ph.D. in neuroanatomy and physiology from the University of Georgia.

Basic Compensation

Total Annual Compensation, USD 198,073
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 30,400
Fiscal Year Total, USD 228,473

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --